Molecular epidemiology of an SHV-5 extended-spectrum ²-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit

90Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Klebsiella oxytoca that produced extended-spectrum ²-lactamase (ESBL) and were resistant to ceftazidime were isolated from infants in a neonatal intensive care unit (NICU). During a 30-week period, 3 infants developed infections and an additional 60 infants were colonized with these bacteria. The molecular typing data suggested transmission of a single strain of ceftazidime-resistant K. oxytoca among 48 of the 63 infants. The ESBL of 46 of the 48 similar isolates, 14 of the remaining 15 isolates, and 6 other Enterobacteriaceae appeared to be associated with a conjugative plasmid of ∼85 kb. The ESBL gene was cloned, and DNA sequencing confirmed that the ESBL was an SHV-5. Hybridization data suggested that the SHV-5 gene was transmitted to other Enterobacteriaceae in vivo. The spread of the ESBL was reduced through adherence to infection-control practices. © 1995 by The University of Chicago.

Cite

CITATION STYLE

APA

Venezia, R. A., Scarano, F. J., Preston, K. E., Steele, L. M., Root, T. P., Limberger, R., … Kacica, M. A. (1995). Molecular epidemiology of an SHV-5 extended-spectrum 2-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clinical Infectious Diseases, 21(4), 915–923. https://doi.org/10.1093/clinids/21.4.915

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free